Open Payments

Cedars-Sinai Medical Center

Type
Teaching hospital
Where
West Hollywood, CA
Medicare CCN
050625
Received
$25,959,593 in 1,319 records, 2021 ($7,042,698 general, $18,916,894 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2021General payment322$7,042,698
2021Research payment997$18,916,894

By company

CompanyRecordsAmountYears
Merck Sharp & Dohme LLC52$4,349,6262021
Siemens Medical Solutions USA, Inc.20$3,492,3502021
Boston Scientific Corporation64$1,994,3512021
Bausch Health US, LLC4$1,508,7912021
Eli Lilly and Company29$1,355,3572021
PFIZER INC.83$1,318,9392021
Edwards Lifesciences Corporation55$1,266,1822021
E.R. Squibb & Sons, L.L.C.19$1,246,9162021
Amgen Inc.10$671,4392021
Genentech, Inc.21$626,8742021
Brahms GmbH14$601,5522021
Janssen Research & Development, LLC28$554,6092021
Takeda Pharmaceuticals U.S.A., Inc.66$510,1952021
Beckman Coulter, Inc.1$350,0002021
Alkermes, Inc.23$316,0352021
AstraZeneca Pharmaceuticals LP20$296,4732021
Gilead Sciences, Inc.45$294,0432021
Biogen, Inc.4$293,6792021
ABBVIE INC.37$285,7602021
Medtronic, Inc.30$231,1892021
Otsuka Pharmaceutical Co., Ltd.9$226,7782021
Exelixis Inc.12$222,9652021
SEAGEN INC.14$191,1602021
Cardiovascular Systems Inc.9$187,4322021
KARL STORZ Endoscopy-America57$178,4962021
Horizon Therapeutics plc4$168,4972021
Intercept Pharmaceuticals, Inc.31$163,7822021
Acutus Medical, Inc.1$144,0002021
TransMedics, Inc.9$143,1512021
Teva Pharmaceuticals USA, Inc.1$133,7312021
Intuitive Surgical, Inc.21$132,6202021
Daiichi Sankyo Inc.8$128,2472021
BioNTech SE14$119,8852021
Karyopharm Therapeutics Inc.5$114,6672021
Alexion Pharmaceuticals, Inc.57$104,7532021
Novartis Pharmaceuticals Corporation5$102,3222021
Cook Research Incorporated3$92,2452021
VIVUS LLC2$91,7132021
Musculoskeletal Transplant Foundation Inc.5$90,8442021
Alnylam Pharmaceuticals Inc.11$83,2482021
ABIOMED3$82,5002021
Travere Therapeutics, Inc.32$76,3662021
Stryker Corporation17$74,7292021
Regeneron Pharmaceuticals, Inc.27$72,6452021
AstraZeneca UK Limited2$63,8102021
Incyte Corporation36$60,4052021
Bayer Healthcare Pharmaceuticals Inc.12$56,7532021
Janssen Scientific Affairs, LLC2$55,0002021
Ethicon Inc.4$51,9422021
Medical Device Business Services, Inc.8$41,0002021

By nature of payment

NatureRecordsAmount
Research payment997$18,916,894
Royalty or License15$4,467,564
Grant82$1,284,996
Education68$437,120
Consulting Fee4$384,200
Space rental or facility fees (teaching hospital only)67$138,325
Compensation for services other than consulting, including serving as faculty or as a speaker at a v14$128,068
Long term medical supply or device loan24$102,222
Debt forgiveness40$98,313
Charitable Contribution1$1,000
Gift7$886

Records

DateCompanyAmountNatureFormProductStudyYear
2021-12-31Merck Sharp & Dohme LLC$876,529Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYPilot Study of Immune Checkpoint Inhibition with Pembrolizumab in Advanced BRCA-mutated Breast Cancers2021
2021-12-31Merck Sharp & Dohme LLC$616,122Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYNeoadjuvant Her2-targeted Therapy and Immunotherapy with Pembrolizumab neoHIP2021
2021-12-31Merck Sharp & Dohme LLC$458,951Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYNeoadjuvant Her2-targeted Therapy and Immunotherapy with Pembrolizumab neoHIP2021
2021-12-31Merck Sharp & Dohme LLC$359,227Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2021
2021-12-31Merck Sharp & Dohme LLC$183,111Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub2021
2021-12-31Merck Sharp & Dohme LLC$104,249Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy2021
2021-12-31Merck Sharp & Dohme LLC$93,184Research paymentIn-kind items and services Biological, INFECTIOUS DISEASEA Phase 2,3 Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety and Pharmacokin2021
2021-12-31Merck Sharp & Dohme LLC$52,921Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2021
2021-12-31Merck Sharp & Dohme LLC$50,336Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYSingle Arm, Open Label Phase 1b,2 Study of Tucatinib in Combination with Trastuzumab and Pembrolizumab in Women with HER2021
2021-12-31Merck Sharp & Dohme LLC$48,098Research paymentIn-kind items and services Drug, ONCOLOGYA PHASE 1, MULTIPLE-DOSE, DOSE-ESCALATION TRIAL OF PT2385 TABLETS, A HIF-2 INHIBITOR, IN PATIENTS WITH ADVANCED CLEAR C2021
2021-12-31Merck Sharp & Dohme LLC$40,821Research paymentIn-kind items and servicesLENVIMA Drug, ONCOLOGYA Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub2021
2021-12-31Merck Sharp & Dohme LLC$29,046Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYAn Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab MK-3475 in Combination with Bel2021
2021-12-31Merck Sharp & Dohme LLC$20,996Research paymentIn-kind items and servicesWELIREG Drug, ONCOLOGYAn Open-label, Randomized, Phase 3 Study of MK-6482 in Combination with Lenvatinib MK-7902 vs Cabozantinib for Treatment2021
2021-12-31Merck Sharp & Dohme LLC$19,848Research paymentIn-kind items and services Drug, ONCOLOGYA Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutatio2021
2021-12-31Merck Sharp & Dohme LLC$19,541Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Randomized, Double-Blind, Phase 3 Study of Pemetrexed Platinum Chemotherapy with or without Pembrolizumab MK-3475 in 2021
2021-12-31Merck Sharp & Dohme LLC$17,190Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy2021
2021-12-31Intuitive Surgical, Inc.$16,840Long term medical supply or device loanIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2021
2021-12-31Merck Sharp & Dohme LLC$10,801Research paymentIn-kind items and servicesWELIREG Drug, ONCOLOGYA Phase 2 Trial of PT2977 in Combination with Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma2021
2021-12-31KARL STORZ Endoscopy-America$10,367EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31Merck Sharp & Dohme LLC$10,093Research paymentIn-kind items and servicesWELIREG Drug, ONCOLOGYAn Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab MK-3475 in Combination with Bel2021
2021-12-31Merck Sharp & Dohme LLC$9,466Research paymentIn-kind items and servicesWELIREG Drug, ONCOLOGYA Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan MK-6482, formerly PT2977 Monotherapy in Participants w2021
2021-12-31Siemens Medical Solutions USA, Inc.$8,250Research paymentCash or cash equivalentCSMC2020MRIPR017Li2021
2021-12-31Merck Sharp & Dohme LLC$6,252Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab MK-3475 in Subjects with High Risk Non-muscl2021
2021-12-31Brahms GmbH$6,000Research paymentIn-kind items and servicesBRAHMS KRYPTOR compact PLUS (instrument) Device, Kryptor instrumentIdentification and Validation of a Cut-off for the Ratio of Soluble Fms-like Tyrosine Kinase-1 to Placental Growth Facto2021
2021-12-31Siemens Medical Solutions USA, Inc.$5,651Research paymentCash or cash equivalentCSMC2021MRIPR941IPR932Li2021
2021-12-31Merck Sharp & Dohme LLC$5,642Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Phase 2, Open-label, Multicenter, Study of an Immunotherapeutic Treatment, DPX-Survivac in combination with Low Dose C2021
2021-12-31Merck Sharp & Dohme LLC$5,057Research paymentIn-kind items and servicesGARDASIL 9 Biological, VACCINEImmunogenicity of Nonavalent HPV Vaccine Administered Prior To Living Donor Renal Transplantation in Adult Women A Prosp2021
2021-12-31Shockwave Medical, Inc$5,000Long term medical supply or device loanIn-kind items and servicesShockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Lithoplasty2021
2021-12-31Intuitive Surgical, Inc.$5,000EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2021
2021-12-31Intuitive Surgical, Inc.$5,000EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2021
2021-12-31Merck Sharp & Dohme LLC$4,635Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Phase III, Randomized, Double-blind Study to Evaluate Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy as 2021
2021-12-31AngioDynamics, Inc.$4,333EducationIn-kind items and servicesSolero Device, Oncology2021
2021-12-31KARL STORZ Endoscopy-America$4,249EducationIn-kind items and servicesn.a. Device, VIDEOIMAGING2021
2021-12-31KARL STORZ Endoscopy-America$3,931EducationIn-kind items and servicesn.a. Device, VIDEOIMAGING2021
2021-12-31Merck Sharp & Dohme LLC$3,387Research paymentIn-kind items and servicesWELIREG Drug, ONCOLOGYA Phase 2 Trial of PT2977 in Combination with Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma2021
2021-12-31Merck Sharp & Dohme LLC$3,308Research paymentIn-kind items and servicesLENVIMA Drug, ONCOLOGYAn Open-label, Randomized, Phase 3 Study of MK-6482 in Combination with Lenvatinib MK-7902 vs Cabozantinib for Treatment2021
2021-12-31Siemens Medical Solutions USA, Inc.$3,000Research paymentCash or cash equivalentCSMC2020MRIPR794IPR992Li2021
2021-12-31KARL STORZ Endoscopy-America$2,856EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31Merck Sharp & Dohme LLC$2,779Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg2021
2021-12-31ABBVIE INC.$2,760Research paymentIn-kind items and servicesAn Open-Label Extension of Studies M15-736 and M20-339 to Evaluate the Safety and Tolerability of 24-Hour Daily Exposure2021
2021-12-31Intuitive Surgical, Inc.$2,720Long term medical supply or device loanIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2021
2021-12-31Intuitive Surgical, Inc.$2,720Long term medical supply or device loanIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2021
2021-12-31AstraZeneca Pharmaceuticals LP$2,578Research paymentIn-kind items and servicesTAGRISSO Drug, OncologyTo assess the efficacy and safety of AZD9291 versus Placebo in patients with Epidermal Growth Factor Receptor Mutation P2021
2021-12-31Rapid Medical Ltd$2,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentTIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, cardiovascular2021
2021-12-31KARL STORZ Endoscopy-America$2,194EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$2,194EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$2,162EducationIn-kind items and servicesn.a. Device, VIDEOIMAGING2021
2021-12-31KARL STORZ Endoscopy-America$2,117EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31Linvatec Corporation$1,973Long term medical supply or device loanIn-kind items and servicesMICROPOWER Device, ORTHOPEDIC SURGERY2021
2021-12-31KARL STORZ Endoscopy-America$1,923EducationIn-kind items and servicesn.a. Device, VIDEOIMAGING2021
2021-12-31Merck Sharp & Dohme LLC$1,890Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Multi-part, Phase 1, Multi-center, Open-label Study of DKN-01 as a Monotherapy or in Combination with Paclitaxel or Pe2021
2021-12-31KARL STORZ Endoscopy-America$1,836EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31Merck Sharp & Dohme LLC$1,818Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Randomized, Double-Blind, Phase 3 Study of Pemetrexed Platinum Chemotherapy with or without Pembrolizumab MK-3475 in 2021
2021-12-31KARL STORZ Endoscopy-America$1,577EducationIn-kind items and servicesLED POWER Device, VIDEOIMAGING2021
2021-12-31Merck Sharp & Dohme LLC$1,524Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Multi-part, Phase 1, Multi-center, Open-label Study of DKN-01 as a Monotherapy or in Combination with Paclitaxel or Pe2021
2021-12-31AstraZeneca Pharmaceuticals LP$1,391Research paymentIn-kind items and servicesLYNPARZA Drug, Oncology\";A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in P2021
2021-12-31KARL STORZ Endoscopy-America$1,308EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31AstraZeneca Pharmaceuticals LP$1,252Research paymentIn-kind items and servicesA Phase 2b Multicenter Randomised Double blind Placebo controlled Study of Verinurad and Allopurinol in Patients with Ch2021
2021-12-31KARL STORZ Endoscopy-America$1,203EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31AstraZeneca Pharmaceuticals LP$1,058Research paymentIn-kind items and servicesA Biomarker-Directed Phase 2 Platform Study in Patients with Advanced Non-Small Cell Lung Cancer whose Disease has Progr2021
2021-12-31Medline Industries LP$1,042Debt forgivenessCash or cash equivalent2021
2021-12-31KARL STORZ Endoscopy-America$971EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31ABBVIE INC.$927Research paymentIn-kind items and servicesA Phase 1 First-in-Human Study with ABBV-155 Alone and in Combination with Taxane Therapy in Adults with Relapsed and/or2021
2021-12-31KARL STORZ Endoscopy-America$898EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$898EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31ABBVIE INC.$849Research paymentIn-kind items and servicesA Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABB2021
2021-12-31Siemens Medical Solutions USA, Inc.$750Research paymentCash or cash equivalentCSMC2019MRIPR785Xie2021
2021-12-31Siemens Medical Solutions USA, Inc.$717Research paymentCash or cash equivalentBiograph mCT X-4R Device, MI - Nuclear Medicine (incl. PETNET & MIBR)Evaluation of new method of cardiac PETCT registration2021
2021-12-31Medline Industries LP$617Debt forgivenessCash or cash equivalent2021
2021-12-31KARL STORZ Endoscopy-America$612EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31Merck Sharp & Dohme LLC$536Research paymentIn-kind items and servicesLYNPARZA Biological, ONCOLOGYA Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutatio2021
2021-12-31AstraZeneca Pharmaceuticals LP$525Research paymentIn-kind items and servicesThis is a randomized open label multi center global Phase III study to assess the efficacy and safety of durvalumab plus2021
2021-12-31Merck Sharp & Dohme LLC$483Research paymentIn-kind items and servicesWELIREG Drug, ONCOLOGYA Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan MK-6482, formerly PT2977 Monotherapy in Participants w2021
2021-12-31KARL STORZ Endoscopy-America$446EducationIn-kind items and servicesn.a. Device, VIDEOIMAGING2021
2021-12-31KARL STORZ Endoscopy-America$427EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$414EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$389EducationIn-kind items and servicesn.a. Device, VIDEOIMAGING2021
2021-12-31KARL STORZ Endoscopy-America$375EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$348EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31Paragonix Technologies, Inc.$315GiftIn-kind items and servicesSherpacool Device, Cardiology2021
2021-12-31KARL STORZ Endoscopy-America$292EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$277EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$274EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31Siemens Medical Solutions USA, Inc.$263Debt forgivenessIn-kind items and services2021
2021-12-31KARL STORZ Endoscopy-America$208EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$186Research paymentIn-kind items and servicesn.a. Device, ANESTHESIOLOGYEvaluation of Utility of Bronchoscopy After Urgent Intubation2021
2021-12-31KARL STORZ Endoscopy-America$125EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$125EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$116EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31Stryker Corporation$116Long term medical supply or device loanIn-kind items and servicesSURGICOUNT Device, SURGICAL2021
2021-12-31KARL STORZ Endoscopy-America$92EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31Stryker Corporation$64Long term medical supply or device loanIn-kind items and servicesSURGICOUNT Device, SURGICAL2021
2021-12-31KARL STORZ Endoscopy-America$53EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31Stryker Corporation$50Debt forgivenessCash or cash equivalent2021
2021-12-31KARL STORZ Endoscopy-America$47EducationIn-kind items and servicesn.a. Device, VIDEOIMAGING2021
2021-12-31KARL STORZ Endoscopy-America$45EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31Stryker Corporation$24Long term medical supply or device loanIn-kind items and servicesSURGICOUNT Device, SURGICAL2021
2021-12-31Stryker Corporation$24Long term medical supply or device loanIn-kind items and servicesSURGICOUNT Device, SURGICAL2021
2021-12-31Stryker Corporation$24Long term medical supply or device loanIn-kind items and servicesSURGICOUNT Device, SURGICAL2021
2021-12-31KARL STORZ Endoscopy-America$22EducationIn-kind items and servicesHOPKINS Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$21EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31Stryker Corporation$13Debt forgivenessCash or cash equivalent2021
2021-12-31KARL STORZ Endoscopy-America$12EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$10EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$8EducationIn-kind items and services Device, LAPAROSCOPY2021
2021-12-31KARL STORZ Endoscopy-America$7EducationIn-kind items and servicesn.a. Device, VIDEOIMAGING2021
2021-12-29Merck Sharp & Dohme LLC$105,617Research paymentCash or cash equivalentKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2021
2021-12-29Abbott Laboratories$610Debt forgivenessCash or cash equivalent2021
2021-12-29Abbott Laboratories$326Debt forgivenessCash or cash equivalent2021
2021-12-28ABBVIE INC.$8,052Research paymentCash or cash equivalentStudy Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor2021
2021-12-23Bayer Healthcare Pharmaceuticals Inc.$4,952Research paymentCash or cash equivalentNon-CoveredCombo with PD-1 inhibitor2021
2021-12-23PFIZER INC.$4,816Research paymentCash or cash equivalentA PHASE 2 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBOCONTROLLED DOSERANGING DOSEFINDING PARALLEL GROUP STUDY TO ASSESS EF2021
2021-12-22Alkermes, Inc.$31,280Research paymentCash or cash equivalentA Phase 2, Open-label, Multicenter, Cohort Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy Administered Subcutaneously2021
2021-12-22Intercept Pharmaceuticals, Inc.$7,439Research paymentCash or cash equivalentStudy Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic 2021
2021-12-22Gilead Sciences, Inc.$1,808Research paymentCash or cash equivalentA Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis2021
2021-12-22Gilead Sciences, Inc.$1,547Research paymentCash or cash equivalentA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of Cilof2021
2021-12-22Concordia Laboratories Inc.$280Research paymentCash or cash equivalentPDT Registry2021
2021-12-21Boston Scientific Corporation$9,253Research paymentCash or cash equivalentCryoablation Device, Breast CancerA Single Arm Phase 2 Study of Peri-Operative Ipilimumab, Nivolumab and Cryoablation in Women with Hormone Receptor-Negat2021
2021-12-21Bausch Health US, LLC$8,791Research paymentCash or cash equivalentXIFAXAN Drug, GastroenterologyAn Open Label Pilot study of Rifaximin in the Treatment of Non-Alcoholic Steatohepatitis2021
2021-12-21Janssen Biotech, Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentSTELARA Biological, Immunology2021
2021-12-21Janssen Research & Development, LLC$1,452Research paymentCash or cash equivalentAn Open label Phase 11b Study to Evaluate the Safety and Pharmacokinetics of JNJ73841937 Lazertinib a Third Generation E2021
2021-12-21Takeda Pharmaceuticals U.S.A., Inc.$780Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-PERIOD CROSSOVER, PHASE 2 STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLE2021
2021-12-20Boston Scientific Corporation$170,233Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTPROTECTED TAVR: STROKE PROTECTION WITH SENTINEL DURING TRANS2021
2021-12-20Gilead Sciences, Inc.$42,056Research paymentCash or cash equivalentA Phase 1a/b Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combinati2021
2021-12-20Boston Scientific Corporation$15,237Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTACURATE IDE: TRANSCATHETER REPLACEMENT OF STENOTIC AORTIC VA2021
2021-12-20Exelixis Inc.$4,100Research paymentCash or cash equivalentCABOMETYX Drug, OncologyStudy of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors2021
2021-12-17Siemens Medical Solutions USA, Inc.$10,000GrantCash or cash equivalent2021
2021-12-17Siemens Medical Solutions USA, Inc.$2,500GrantCash or cash equivalent2021
2021-12-17Epizyme, Inc.$2,280Research paymentCash or cash equivalentTAZVERIK Drug, ONCOLOGYA PHASE 1, OPEN-LABEL MULTI-DOSE TWO-PART STUDY TO CHARACTERIZE THE EFFECTS OF A STRONG CYP3A4 INHIBITOR ON THE STEADY-S2021
2021-12-17Bayer Healthcare Pharmaceuticals Inc.$2,200Space rental or facility fees (teaching hospital only)Cash or cash equivalentVitrakvi Drug, Oncology2021
2021-12-17Merck Sharp & Dohme LLC$1,860Research paymentCash or cash equivalentKEYTRUDA Biological, ONCOLOGYA Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab MK-3475 in Subjects with High Risk Non-muscl2021
2021-12-17MEDIVATION LLC.$1,835Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS2021
2021-12-17W. L. Gore & Associates, Inc.$1,024Research paymentCash or cash equivalentProduct in Development Device, DevicesEvaluation of the GORE TAG TSSB LSA Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms2021
2021-12-17Medtronic, Inc.$500Research paymentCash or cash equivalentMicra Device, PacemakersPSR-CVG2021
2021-12-17Epizyme, Inc.$54Research paymentCash or cash equivalentTAZVERIK Drug, ONCOLOGYA PHASE 1, OPEN-LABEL MULTI-DOSE TWO-PART STUDY TO CHARACTERIZE THE EFFECTS OF A STRONG CYP3A4 INHIBITOR ON THE STEADY-S2021
2021-12-17Epizyme, Inc.$39Research paymentCash or cash equivalentTAZVERIK Drug, ONCOLOGYA PHASE 1, OPEN-LABEL MULTI-DOSE TWO-PART STUDY TO CHARACTERIZE THE EFFECTS OF A STRONG CYP3A4 INHIBITOR ON THE STEADY-S2021
2021-12-16Cook Research Incorporated$81,270Research paymentCash or cash equivalentGastral Jejunal Feeding Tubes Study2021
2021-12-16Janssen Research & Development, LLC$26,380Research paymentCash or cash equivalentA Randomized Double blind Placebo controlled Phase 3 Study of Apalutamide in Subjects with High risk Localized or Locall2021
2021-12-16PROGENICS PHARMACEUTICALS, INC.$4,600Research paymentCash or cash equivalentPYLARIFY Drug, RADIOPHARMACEUTICALHigh-Resolution, 18F-PSMA PET-MRI for Mapping Prostate Cancer in Patients Considering Focal High-Intensity Focused Ultra2021
2021-12-16Zimmer Biomet Holdings, Inc.$4,550Research paymentCash or cash equivalentROSA-Knee Device, KneesThe accuracy and reproducibility of Zimmer Biomet ROSA in helping surgeons achieve a target hip-knee-angle2021
2021-12-16Zimmer Biomet Holdings, Inc.$4,550Research paymentCash or cash equivalentROSA-Knee Device, KneesEarly radiographic and clinical outcomes in low volume surgeons performing robotic assisted total knee arthroplasty comp2021
2021-12-16Janssen Research & Development, LLC$2,979Research paymentCash or cash equivalentA Randomized Double blind Placebo controlled Phase 3 Study of Apalutamide in Subjects with High risk Localized or Locall2021
2021-12-16ABBVIE INC.$2,259Research paymentCash or cash equivalentSKYRIZI Biological, IMMUNOLOGYA Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the2021
2021-12-16Abbott Laboratories$1,350Consulting FeeCash or cash equivalentDragonfly OCT Device, Vascular2021
2021-12-16Cook Research Incorporated$525Research paymentCash or cash equivalentGastral Jejunal Feeding Tubes Study2021
2021-12-16SEAGEN INC.$397Research paymentCash or cash equivalentPhase 1b/2 study of SGN-LIV1A in combination with pembrolizumab in patients with locally advanced or metastatic triple-n2021
2021-12-16Eli Lilly and Company$21Research paymentIn-kind items and servicesA RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD2021
2021-12-15Karyopharm Therapeutics Inc.$56,780Research paymentCash or cash equivalentXPOVIO Drug, OncologySelinexor in liposarcoma: molecular mechanisms, drug combo and biomarkers2021
2021-12-15Gilead Sciences, Inc.$11,660Research paymentCash or cash equivalentVeklury Drug, COVID-19A Phase 1b/2a study in A Phase 1b/2a Study in Participants with Early Stage COVID-19 to Evaluate the Safety, Efficacy, a2021
2021-12-15Kaneka Medical America LLC$6,531Consulting Fee (12 payments)Cash or cash equivalentLIPOSORBER Device, Lipid Apheresis2021
2021-12-15Intercept Pharmaceuticals, Inc.$2,472Research paymentCash or cash equivalentOCALIVA Drug, HEPATOLOGY GASTROENTEROLOGYRandomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)2021
2021-12-15Gilead Sciences, Inc.$2,396Research paymentCash or cash equivalentVeklury Drug, COVID-19A Phase 1b/2a study in A Phase 1b/2a Study in Participants with Early Stage COVID-19 to Evaluate the Safety, Efficacy, a2021
2021-12-15BONE SUPPORT AB$730Research paymentCash or cash equivalentCERAMENT G Device, Bone void and fractureA Prospective, Randomized Multicenter Controlled Trial of CERAMENT G as Part of Surgical Repair of Open Diaphyseal Tibia2021
2021-12-15Medtronic, Inc.$268Research paymentCash or cash equivalentINTERSTIM Device, Sacral Nerve StimulationELITE2021
2021-12-14Novartis Pharmaceuticals Corporation$13,000Research paymentCash or cash equivalent DrugA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACO2021
2021-12-14Abbott Laboratories$3,547Research paymentIn-kind items and servicesAlinity i System Device, Core DiagnosticsARS-CoV-2 IgG Quantitative Assay System Suitability Study on Alinity i2021
2021-12-14Daiichi Sankyo Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentINJECTAFER Drug, Iron Deficiency Anemia2021
2021-12-14Abbott Laboratories$832Debt forgivenessCash or cash equivalent2021
2021-12-14Abbott Laboratories$400Debt forgivenessCash or cash equivalent2021
2021-12-10PFIZER INC.$600Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2021
2021-12-09PFIZER INC.$41,028Research paymentIn-kind items and servicesTALZENNA Drug, ONCOLOGYA PHASE 1 OPEN LABEL CROSSOVER STUDY TO ESTABLISH BIOEQUIVALENCE BETWEEN THE PROPOSED SOFT GEL TALAZOPARIB CAPSULE FORMU2021
2021-12-09Blueprint Medicines Corporation$26,550Research paymentCash or cash equivalentBLU-945-11012021
2021-12-09Blueprint Medicines Corporation$6,644Research paymentCash or cash equivalentBLU-945-11012021
2021-12-09Blueprint Medicines Corporation$2,600Research paymentCash or cash equivalentBLU-945-11012021
2021-12-09Blueprint Medicines Corporation$2,000Research paymentCash or cash equivalentBLU-945-11012021
2021-12-09Blueprint Medicines Corporation$1,430Research paymentCash or cash equivalentBLU-945-11012021
2021-12-09Blueprint Medicines Corporation$1,300Research paymentCash or cash equivalentBLU-945-11012021
2021-12-08Musculoskeletal Transplant Foundation Inc.$15,844Research paymentCash or cash equivalentElbow Ulnar Collateral Ligament Reconstruction with Knee Collateral Ligament allograft a biomechanical study2021
2021-12-08Gilead Sciences, Inc.$6,550Research paymentCash or cash equivalentA Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients with Myeloid Malignancies2021
2021-12-08United Therapeutics Corporation$2,392Research paymentCash or cash equivalentORENITRAM Drug, PAHADAPT - A PATIENT REGISTRY OF THE REAL-WORLD USE OF ORENITRAM2021
2021-12-08PFIZER INC.$384Research paymentCash or cash equivalentA PHASE 2 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBOCONTROLLED DOSERANGING DOSEFINDING PARALLEL GROUP STUDY TO ASSESS EF2021
2021-12-08Takeda Pharmaceuticals U.S.A., Inc.$194Research paymentCash or cash equivalentA PHASE-III, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, INTERNATIONAL, MULTICENTRE STUDY TO ASSESS EF2021
2021-12-08Takeda Pharmaceuticals U.S.A., Inc.$116Research paymentCash or cash equivalentA PHASE-III, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, INTERNATIONAL, MULTICENTRE STUDY TO ASSESS EF2021
2021-12-08Takeda Pharmaceuticals U.S.A., Inc.$32Research paymentCash or cash equivalentA PHASE-III, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, INTERNATIONAL, MULTICENTRE STUDY TO ASSESS EF2021
2021-12-07TransMedics, Inc.$26,300Research paymentCash or cash equivalentORGAN CARE SYSTEM Device, DEVICEOCS-CAR08240202021
2021-12-06Takeda Pharmaceuticals U.S.A., Inc.$81,223GrantCash or cash equivalent2021
2021-12-06Edwards Lifesciences Corporation$23,050Research paymentCash or cash equivalentThe SURPASS Study 2017-152021
2021-12-06Gilead Sciences, Inc.$1,000Research paymentCash or cash equivalentHarvoni Drug, HCVA Long Term Follow-up Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response to Treatment for H2021
2021-12-06Boston Scientific Corporation$681Research paymentCash or cash equivalentVARIOUS RELEASED ICD FAMILIES Device, Clinical Trial ProductASAP TOO2021
2021-12-06ZOLL Medical Corporation$300Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, DEFIBRILLATOR2021
2021-12-02Alexion Pharmaceuticals, Inc.$10,000GrantCash or cash equivalent2021
2021-12-02IBSA Institut Biochimique SA$5,000GrantCash or cash equivalent2021
2021-12-02PFIZER INC.$3,445Research paymentCash or cash equivalentBAVENCIO Drug, ONCOLOGYA PHASE 3 MULTINATIONAL RANDOMIZED OPENLABEL PARALLELARM STUDY OF AVELUMAB MSB0010718C IN COMBINATION WITH AXITINIB INLY2021
2021-12-02AstraZeneca Pharmaceuticals LP$1,500GrantCash or cash equivalent2021
2021-12-02PFIZER INC.$975Research paymentCash or cash equivalentBAVENCIO Drug, ONCOLOGYA PHASE 3 MULTINATIONAL RANDOMIZED OPENLABEL PARALLELARM STUDY OF AVELUMAB MSB0010718C IN COMBINATION WITH AXITINIB INLY2021
2021-12-01Merck Sharp & Dohme LLC$144,714Research paymentCash or cash equivalentKEYTRUDA Biological, ONCOLOGYPilot Study of Immune Checkpoint Inhibition with Pembrolizumab in Advanced BRCA-mutated Breast Cancers2021
2021-12-01PFIZER INC.$18,861Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTA2021
2021-12-01Gilead Sciences, Inc.$7,076Research paymentCash or cash equivalentVeklury Drug, COVID-19A Phase 1b/2a study in A Phase 1b/2a Study in Participants with Early Stage COVID-19 to Evaluate the Safety, Efficacy, a2021
2021-12-01PROGENICS PHARMACEUTICALS, INC.$4,600Research paymentCash or cash equivalentPYLARIFY Drug, RADIOPHARMACEUTICALHigh-Resolution, 18F-PSMA PET-MRI for Mapping Prostate Cancer in Patients Considering Focal High-Intensity Focused Ultra2021
2021-12-01Roche Products Limited$2,982Research paymentCash or cash equivalentOCREVUS Biological, ImmunologyOBSERVATIONAL STUDY OF OCRELIZUMAB TREATED MULTIPLE SCLEROSIS PATIENTS US COMMITMENT2021
2021-11-30PFIZER INC.$600Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2021
2021-11-29Amgen Inc.$20,235Research paymentIn-kind items and servicesRepatha Biological, CardiologyEffect of evolocumab on coronary artery plaque volume and composition by coronary CTA (CCTA) and microcalcification by F2021
2021-11-29Medtronic, Inc.$3,935Research paymentCash or cash equivalentINTERSTIM Device, Sacral Nerve StimulationELITE2021
2021-11-29Janssen Research & Development, LLC$3,080Research paymentCash or cash equivalentA Phase 1 First inhuman Open Label Dose Escalation Study of JNJ61186372 a Human Bispecific EGFR and cMet Antibody in Sub2021
2021-11-26Boston Scientific Corporation$18,507Research paymentCash or cash equivalentCryoablation Device, Breast CancerA Single Arm Phase 2 Study of Peri-Operative Ipilimumab, Nivolumab and Cryoablation in Women with Hormone Receptor-Negat2021
2021-11-26Ethicon Inc.$6,089Research paymentCash or cash equivalentNeuwave Device, Ablation SystemA Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue2021
2021-11-26Genentech, Inc.$4,643Research paymentCash or cash equivalentActemra Biological, ImmunologyPHIB STUDY OF RO6958688 AND ATEZOLIZUMAB IN 3L MSS MCRC PTS AFTER PRETX WITH OBINUTUZUMAB2021
2021-11-26PFIZER INC.$2,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE2021
2021-11-25Janssen Research & Development, LLC$5,171Research paymentCash or cash equivalentAn Open label Phase 11b Study to Evaluate the Safety and Pharmacokinetics of JNJ73841937 Lazertinib a Third Generation E2021
2021-11-24Edwards Lifesciences Corporation$93,231Research paymentCash or cash equivalentTRISCEND II Pivotal (2020-05)2021

The latest 200 records of 1,319.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Los Angeles CountyWest Hollywood city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In West Hollywood, CA, county Los Angeles County, CA, state California; placed by its city name.

MeasurePlace (city or town)
West Hollywood, CA
County
Los Angeles County, CA
State
California
Population B0100334,8849,808,66739,287,377
Population, 2020 census P135,75710,014,00939,538,223
Median age B0100240.038.237.9
Under 18 B010013.6%20.6%22.0%
65 and over B0100116.8%15.2%15.7%
Households B1100122,9203,416,44913,548,091
Foreign born B0500223.6%33.4%27.0%
Median household income B19013$96,995$90,112$99,122
Median family income B19113$126,364$101,573$113,346
Per capita income B19301$90,080$45,792$49,513
Poverty rate B1700112.9%13.7%12.0%
Unemployment rate B230258.9%7.3%6.6%
Civilian labor force B2302525,8185,200,65620,068,466
Mean commute (minutes) B0801327.130.428.7
Bachelor's degree or higher B1500364.2%36.0%37.1%
Housing units B2500126,0793,650,46614,644,735
Owner-occupied B2500319.8%45.9%55.9%
Renters B2500380.2%54.1%44.1%
Median home value B25077$924,800$834,200$734,700
Median gross rent B25064$2,091$1,954$2,036
White, not Hispanic B0300269.5%24.7%33.8%
Black B030024.3%7.4%5.2%
Hispanic or Latino B0300213.1%48.4%40.2%
Asian B030026.1%14.9%15.3%
American Indian and Alaska Native B030020.1%0.2%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in West Hollywood, CA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.